Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

70.32
Delayed Data
As of Mar 24
 +1.79 / +2.61%
Today’s Change
11.57
Today|||52-Week Range
74.94
+58.31%
Year-to-Date
Look for Clovis Oncology to Resume Its Advance
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close68.53
Today’s open68.58
Day’s range68.54 - 70.98
Volume1,327,294
Average volume (3 months)2,179,834
Market cap$3.1B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+41.46%
Earnings growth (next 5 years)+24.51%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.05+0.04%
PBHPrestige Brands Hold...-0.12-0.21%
RAREUltragenyx Pharmaceu...-1.67-2.32%
ICPTIntercept Pharmaceut...+0.93+0.80%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$1.48
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs